The dependence of autologous chondrocyte transplantation on varying cellular passage, yield and culture duration

Biomaterials

Volumn 32, Issue 25, 2011, Pages 5810-5818

  Salzmann, Gian M ^a   Sauerschnig, Martin ^b   Berninger, Markus T ^b   Kaltenhauser, Theresa ^b   Schönfelder, Martin ^c   Vogt, Stephan ^b   Wexel, Gabriele ^b   Tischer, Thomas ^d   Sudkamp, Norbert ^a   Niemeyer, Philipp ^a   Imhoff, Andreas B ^b   Schöttle, Philip B ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cartilage; Chondrocyte; Chondrocyte transplantation; Matrix assisted; Tissue engineering

Indexed keywords

ARTICULAR CHONDROCYTES; AUTOLOGOUS CHONDROCYTE TRANSPLANTATIONS; BI-LAYER; CELL MATRIX; CELL YIELDS; CHONDRAL DEFECTS; CHONDROCYTES; CHONDROGENIC DIFFERENTIATION; COLLAGEN I; CULTURE PARAMETERS; EXPRESSION PATTERNS; IN-VITRO; IN-VITRO ANALYSIS; IN-VIVO; LINEAR MODEL; MATRIX-ASSISTED; MRNA EXPRESSION; MULTIPLE REGRESSION ANALYSIS; RABBIT KNEES;

ANIMALS; BODY FLUIDS; CELLS; COLLAGEN; GENE EXPRESSION; IMPLANTS (SURGICAL); MATRIX ALGEBRA; NUCLEIC ACIDS; OPTIMIZATION; REGRESSION ANALYSIS; TISSUE; TISSUE ENGINEERING;

ANIMAL CELL CULTURE;

AGGRECAN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; MESSENGER RNA; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL REGENERATION; CELL TRANSPLANTATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KNEE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; BASE SEQUENCE; CHONDROCYTES; DNA PRIMERS; PROTEINS; RABBITS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 79957921036     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.073     Document Type: Article

References (45)

1. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895.
2. Gomoll A.H., Farr J., Gillogly S.D., Kercher J., Minas T. Surgical management of articular cartilage defects of the knee. J Bone Joint Surg Am 2010, 92:2470-2490.
3. Peterson L., Vasiliadis H.S., Brittberg M., Lindahl A. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 2010, 38:1117-1124.
4. Marlovits S., Zeller P., Singer P., Resinger C., Vecsei V. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 2006, 57:24-31.
5. Knutsen G., Drogset J.O., Engebretsen L., Grontvedt T., Isaksen V., Ludvigsen T.C., et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2007, 89:2105-2112.
6. Saris D.B., Vanlauwe J., Victor J., Almqvist K.F., Verdonk R., Bellemans J., et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med 2009, 37(Suppl. 1). 10S-9S.
7. Bartlett W., Skinner J.A., Gooding C.R., Carrington R.W., Flanagan A.M., Briggs T.W., et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br 2005, 87:640-645.
8. Zeifang F., Oberle D., Nierhoff C., Richter W., Moradi B., Schmitt H. Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial. Am J Sports Med 2010, 38:924-933.
9. Erggelet C., Kreuz P.C., Mrosek E.H., Schagemann J.C., Lahm A., Ducommun P.P., et al. Autologous chondrocyte implantation versus ACI using 3D-bioresorbable graft for the treatment of large full-thickness cartilage lesions of the knee. Arch Orthop Trauma Surg 2010, 130:957-964.
10. Vasiliadis H.S., Wasiak J. Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee. Cochrane Database Syst Rev 2010, CD003323.
11. Temenoff J.S., Mikos A.G. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000, 21:431-440.
12. Concaro S., Nicklasson E., Ellowsson L., Lindahl A., Brittberg M., Gatenholm P. Effect of cell seeding concentration on the quality of tissue engineered constructs loaded with adult human articular chondrocytes. J Tissue Eng Regen Med 2008, 2:14-21.
13. Veilleux N.H., Yannas I.V., Spector M. Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro. Tissue Eng 2004, 10:119-127.
14. Gavenis K., Schmidt-Rohlfing B., Mueller-Rath R., Andereya S., Schneider U. In vitro comparison of six different matrix systems for the cultivation of human chondrocytes. In Vitro Cell Dev Biol Anim 2006, 42:159-167.
15. Ueblacker P., Wagner B., Vogt S., Salzmann G., Wexel G., Kruger A., et al. In vivo analysis of retroviral gene transfer to chondrocytes within collagen scaffolds for the treatment of osteochondral defects. Biomaterials 2007, 28:4480-4487.
16. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
17. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
18. Marijnissen W.J., van Osch G.J., Aigner J., Verwoerd-Verhoef H.L., Verhaar J.A. Tissue-engineered cartilage using serially passaged articular chondrocytes. Chondrocytes in alginate, combined in vivo with a synthetic (E210) or biologic biodegradable carrier (DBM). Biomaterials 2000, 21:571-580.
19. Schnabel M., Marlovits S., Eckhoff G., Fichtel I., Gotzen L., Vecsei V., et al. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002, 10:62-70.
20. Vogt S., Ueblacker P., Geis C., Wagner B., Wexel G., Tischer T., et al. Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector. Biomaterials 2008, 29:1242-1249.
21. Steinwachs M. New technique for cell-seeded collagen-matrix-supported autologous chondrocyte transplantation. Arthroscopy 2009, 25:208-211.
22. Crawford D.C., Heveran C.M., Cannon W.D., Foo L.F., Potter H.G. An autologous cartilage tissue implant NeoCart for treatment of grade III chondral injury to the distal femur: prospective clinical safety trial at 2 years. Am J Sports Med 2009, 37:1334-1343.
23. McCormick F., Yanke A., Provencher M.T., Cole B.J. Minced articular cartilage-basic science, surgical technique, and clinical application. Sports Med Arthrosc 2008, 16:217-220.
24. Quinn T.M., Hunziker E.B., Hauselmann H.J. Variation of cell and matrix morphologies in articular cartilage among locations in the adult human knee. Osteoarthritis Cartilage 2005, 13:672-678.
25. Hunziker E.B., Quinn T.M., Hauselmann H.J. Quantitative structural organization of normal adult human articular cartilage. Osteoarthritis Cartilage 2002, 10:564-572.
26. Pestka J.M., Schmal H., Salzmann G., Hecky J., Sudkamp N.P., Niemeyer P. In vitro cell quality of articular chondrocytes assigned for autologous implantation in dependence of specific patient characteristics. Arch Orthop Trauma Surg 2010.
27. Dell'Accio F., De Bari C., Luyten F.P. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum 2001, 44:1608-1619.
28. Schmal H., Niemeyer P., Zwingmann J., Stoffel F., Sudkamp N.P., Mehlhorn A.T. Association between expression of the bone morphogenetic proteins 2 and 7 in the repair of circumscribed cartilage lesions with clinical outcome. BMC Musculoskelet Disord 2010, 11:170.
29. Brun P., Dickinson S.C., Zavan B., Cortivo R., Hollander A.P., Abatangelo G. Characteristics of repair tissue in second-look and third-look biopsies from patients treated with engineered cartilage: relationship to symptomatology and time after implantation. Arthritis Res Ther 2008, 10:R132.
30. Kang S.W., Yoo S.P., Kim B.S. Effect of chondrocyte passage number on histological aspects of tissue-engineered cartilage. Biomed Mater Eng 2007, 17:269-276.
31. Willers C., Chen J., Wood D., Xu J., Zheng M.H. Autologous chondrocyte implantation with collagen bioscaffold for the treatment of osteochondral defects in rabbits. Tissue Eng 2005, 11:1065-1076.
32. Khoshfetrat A.B., Kino-Oka M., Takezawa Y., Yamamoto T., Sugawara K., Taya M. Seeding density modulates migration and morphology of rabbit chondrocytes cultured in collagen gels. Biotechnol Bioeng 2009, 102:294-302.
33. Goldring M.B., Tsuchimochi K., Ijiri K. The control of chondrogenesis. J Cell Biochem 2006, 97:33-44.
34. Vogt S., Wexel G., Tischer T., Schillinger U., Ueblacker P., Wagner B., et al. The influence of the stable expression of BMP2 in fibrin clots on the remodelling and repair of osteochondral defects. Biomaterials 2009, 30:2385-2392.
35. Moretti M., Wendt D., Dickinson S.C., Sims T.J., Hollander A.P., Kelly D.J., et al. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng 2005, 11:1421-1428.
36. Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med 2010, 38:1259-1271.
37. Darling E.M., Athanasiou K.A. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 2005, 23:425-432.
38. Salzmann G.M., Nuernberger B., Schmitz P., Anton M., Stoddart M.J., Grad S., et al. Physicobiochemical synergism through gene therapy and functional tissue engineering for in vitro chondrogenesis. Tissue Eng Part A 2009, 15:2513-2524.
39. Lee C.R., Grodzinsky A.J., Hsu H.P., Spector M. Effects of a cultured autologous chondrocyte-seeded type II collagen scaffold on the healing of a chondral defect in a canine model. J Orthop Res 2003, 21:272-281.
40. Mauck R.L., Soltz M.A., Wang C.C., Wong D.D., Chao P.H., Valhmu W.B., et al. Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J Biomech Eng 2000, 122:252-260.
41. Lee C.R., Grodzinsky A.J., Spector M. The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. Biomaterials 2001, 22:3145-3154.
42. Reinholz G.G., Lu L., Saris D.B., Yaszemski M.J., O'Driscoll S.W. Animal models for cartilage reconstruction. Biomaterials 2004, 25:1511-1521.
43. Nuernberger S., Cyran N., Albrecht C., Redl H., Vecsei V., Marlovits S. The influence of scaffold architecture on chondrocyte distribution and behavior in matrix-associated chondrocyte transplantation grafts. Biomaterials 2011, 32:1032-1040.
44. Wernike E., Li Z., Alini M., Grad S. Effect of reduced oxygen tension and long-term mechanical stimulation on chondrocyte-polymer constructs. Cell Tissue Res 2008, 331:473-483.
45. Grad S., Gogolewski S., Alini M., Wimmer M.A. Effects of simple and complex motion patterns on gene expression of chondrocytes seeded in 3D scaffolds. Tissue Eng 2006, 12:3171-3179.